EnBio Holdings, Inc (TYO:6092)

EnBio Holdings Statistics

Total Valuation

EnBio Holdings has a market cap or net worth of JPY 5.78 billion. The enterprise value is 12.45 billion.

Market Cap	5.78B
Enterprise Value	12.45B

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	Mar 30, 2026

Share Statistics

EnBio Holdings has 8.12 million shares outstanding. The number of shares has increased by 0.20% in one year.

Current Share Class	8.12M
Shares Outstanding	8.12M
Shares Change (YoY)	+0.20%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	19.16%
Owned by Institutions (%)	8.46%
Float	3.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.50
PB Ratio	0.65
P/TBV Ratio	0.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-70.20
EV / Sales	1.08
EV / EBITDA	n/a
EV / EBIT	11.08
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.22, with a Debt / Equity ratio of 1.18.

Current Ratio	2.22
Quick Ratio	1.24
Debt / Equity	1.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	6.60

Financial Efficiency

Return on equity (ROE) is -2.32% and return on invested capital (ROIC) is -5.97%.

Return on Equity (ROE)	-2.32%
Return on Assets (ROA)	3.30%
Return on Invested Capital (ROIC)	-5.97%
Return on Capital Employed (ROCE)	6.58%
Weighted Average Cost of Capital (WACC)	1.95%
Revenue Per Employee	114.64M
Profits Per Employee	-1.76M
Employee Count	101
Asset Turnover	0.54
Inventory Turnover	2.53

Taxes

In the past 12 months, EnBio Holdings has paid 455.90 million in taxes.

Income Tax	455.90M
Effective Tax Rate	183.74%

Stock Price Statistics

The stock price has increased by +19.66% in the last 52 weeks. The beta is 0.72, so EnBio Holdings's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+19.66%
50-Day Moving Average	627.98
200-Day Moving Average	620.55
Relative Strength Index (RSI)	63.86
Average Volume (20 Days)	39,860

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EnBio Holdings had revenue of JPY 11.58 billion and -177.31 million in losses. Loss per share was -21.90.

Revenue	11.58B
Gross Profit	3.14B
Operating Income	1.12B
Pretax Income	248.12M
Net Income	-177.31M
EBITDA	n/a
EBIT	1.12B
Loss Per Share	-21.90

Balance Sheet

The company has 3.91 billion in cash and 10.50 billion in debt, with a net cash position of -6.58 billion or -811.08 per share.

Cash & Cash Equivalents	3.91B
Total Debt	10.50B
Net Cash	-6.58B
Net Cash Per Share	-811.08
Equity (Book Value)	8.92B
Book Value Per Share	1,087.88
Working Capital	5.71B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 27.15%, with operating and profit margins of 9.71% and -1.53%.

Gross Margin	27.15%
Operating Margin	9.71%
Pretax Margin	2.14%
Profit Margin	-1.53%
EBITDA Margin	n/a
EBIT Margin	9.71%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 9.00, which amounts to a dividend yield of 1.33%.

Dividend Per Share	9.00
Dividend Yield	1.33%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.20%
Shareholder Yield	1.21%
Earnings Yield	-3.07%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EnBio Holdings has an Altman Z-Score of 1.51 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.51
Piotroski F-Score	3